Epinephrine
AlkaPlorer ID: AK001160
Synonym: None
IUPAC Name: 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
Structure
SMILES: CNC[C@H](O)C1=CC=C(O)C(O)=C1
InChI: InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1
InChIKey: UCTWMZQNUQWSLP-VIFPVBQESA-N
Reference
Pregnane glycosides from Hemidesmus indicus
PubChem CID: 139148732
LOTUS: LTS0235972
SuperNatural Ⅲ: SN0366977-02
NPASS: NPC236347
Source
Properties Information
Molecule Weight: 183.207
TPSA?: 72.72
MolLogP?: 0.3506000000000001
Number of H-Donors: 4
Number of H-Acceptors: 4
RingCount: 1
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Potency | 7079.5 | nM | None |
| Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Potency | 50118.7 | nM | None |
| Bos taurus | Beta-2 adrenergic receptor | -Delta G | nan | None | 10.1021/jm00401a004 |
| Bos taurus | Progesterone receptor | IC50 | nan | None | None |
| Bos taurus | Progesterone receptor | Ki | nan | None | None |
| Canis lupus familiaris | Beta-2 adrenergic receptor | Ki | 660.0 | nM | 10.1021/jm990599h |
| Canis lupus familiaris | Beta-2 adrenergic receptor | Ki | 1100.0 | nM | 10.1021/jm990599h |
| Cavia porcellus | Beta-1 adrenergic receptor | EC50 | 15.0 | nM | 10.1021/jm00019a001 |
| Cavia porcellus | Beta-1 adrenergic receptor | EC50 | 260.0 | nM | 10.1021/jm00118a019 |
| Cavia porcellus | Beta-1 adrenergic receptor | EC50 | 436.0 | nM | 10.1021/jm00019a001 |
| Cavia porcellus | Beta-1 adrenergic receptor | Ki | 3000.0 | nM | 10.1021/jm00118a019 |
| Cavia porcellus | Beta-2 adrenergic receptor | EC50 | 15.0 | nM | 10.1021/jm00019a001 |
| Cavia porcellus | Beta-2 adrenergic receptor | EC50 | 436.0 | nM | 10.1021/jm00019a001 |
| Cavia porcellus | Cavia porcellus | EC50 | 400.0 | nM | 10.1021/jm00076a024 |
| Cavia porcellus | Leukotriene C4 synthase | IC50 | nan | None | None |
| Cavia porcellus | Leukotriene C4 synthase | Ki | nan | None | None |
| Cavia porcellus | Serotonin 4 (5-HT4) receptor | IC50 | nan | None | None |
| Cavia porcellus | Serotonin 4 (5-HT4) receptor | Ki | nan | None | None |
| Danio rerio | Danio rerio | Activity | nan | None | 10.1038/nchembio.307 |
| Felis catus | Felis catus | Arterial pressure | 23.8 | mmHg | 10.1021/jm00368a014 |
| Felis catus | Felis catus | Arterial pressure | 50.4 | mmHg | 10.1021/jm00368a014 |
| Felis catus | Felis catus | Heart rate | 47.4 | beats min-1 | 10.1021/jm00368a014 |
| Felis catus | Felis catus | Heart rate | 57.0 | beats min-1 | 10.1021/jm00368a014 |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 11193.6 | nM | None |
| Homo sapiens | Acetylcholinesterase | IC50 | nan | None | None |
| Homo sapiens | Acetylcholinesterase | Ki | nan | None | None |
| Homo sapiens | Adenosine A1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A1 receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A1 receptor | Ki | nan | None | None |
| Homo sapiens | Adenosine A2a receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A2a receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A2a receptor | Ki | nan | None | None |
| Homo sapiens | Adenosine A3 receptor | AC50 | 17999.9 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A3 receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A3 receptor | Ki | nan | None | None |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Inhib (Mean) | -37.43 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Max (Mean) | 36.67 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adrenergic receptor alpha-2 | EC50 | 300.0 | nM | 10.1021/jm00118a019 |
| Homo sapiens | Adrenergic receptor alpha-2 | IC50 | 8.0 | nM | 10.1021/jm00390a021 |
| Homo sapiens | Adrenergic receptor alpha-2 | Ki | 5.0 | nM | 10.1021/jm00118a019 |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 14125.4 | nM | None |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 2.6 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 6.5 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 6.7 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-1a adrenergic receptor | EC50 | 400.0 | nM | 10.1021/jm00118a019 |
| Homo sapiens | Alpha-1a adrenergic receptor | Ki | 2000.0 | nM | 10.1021/jm00118a019 |
| Homo sapiens | Alpha-1b adrenergic receptor | EC50 | 75.0 | nM | 10.1021/acs.jnatprod.9b00418 |
| Homo sapiens | Alpha-1d adrenergic receptor | IC50 | 449.0 | nM | None |
| Homo sapiens | Alpha-1d adrenergic receptor | Ki | 221.0 | nM | None |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 11.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 84.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 8500.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | EC50 | 30.2 | nM | 10.1016/j.bmc.2016.05.043 |
| Homo sapiens | Alpha-2a adrenergic receptor | IC50 | 737.0 | nM | None |
| Homo sapiens | Alpha-2a adrenergic receptor | %Inhib (Mean) | -72.66 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | Ki | 160.0 | nM | 10.1016/j.bmc.2016.05.043 |
| Homo sapiens | Alpha-2a adrenergic receptor | Ki | 276.0 | nM | None |
| Homo sapiens | Alpha-2a adrenergic receptor | %Max (Mean) | 133.26 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2b adrenergic receptor | AC50 | 4000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2b adrenergic receptor | AC50 | 7799.9 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2b adrenergic receptor | IC50 | 869.0 | nM | None |
| Homo sapiens | Alpha-2b adrenergic receptor | Ki | 397.0 | nM | None |
| Homo sapiens | Alpha-2c adrenergic receptor | AC50 | 2700.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2c adrenergic receptor | AC50 | 10999.9 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2c adrenergic receptor | IC50 | 2449.0 | nM | None |
| Homo sapiens | Alpha-2c adrenergic receptor | Ki | 356.0 | nM | None |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | IC50 | nan | None | None |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | Ki | nan | None | None |
| Homo sapiens | Apelin receptor | %Inhib (Mean) | -7.63 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Apelin receptor | %Max (Mean) | -2.294 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Arachidonate 12-lipoxygenase | Potency | 28183.8 | nM | None |
| Homo sapiens | ATP-dependent DNA helicase Q1 | Potency | 17782.8 | nM | None |
| Homo sapiens | ATP-dependent DNA helicase Q1 | Potency | 112201.8 | nM | None |
| Homo sapiens | Beta-1 adrenergic receptor | AC50 | 970.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Beta-1 adrenergic receptor | EC50 | 290.0 | nM | 10.1021/acs.jnatprod.9b00418 |
| Homo sapiens | Beta-1 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-1 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Beta-2 adrenergic receptor | AC50 | 22.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Beta-2 adrenergic receptor | -Delta G | 6.92 | None | 10.1021/jm00401a004 |
| Homo sapiens | Beta-2 adrenergic receptor | -Delta G | 10.11 | None | 10.1021/jm00401a004 |
| Homo sapiens | Beta-2 adrenergic receptor | IC50 | 284.0 | nM | None |
| Homo sapiens | Beta-2 adrenergic receptor | %Inhib (Mean) | -172.54 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-2 adrenergic receptor | Kd | 630.0 | nM | 10.1016/j.ejmech.2008.12.016 |
| Homo sapiens | Beta-2 adrenergic receptor | Kd | 630.96 | nM | 10.1016/j.bmcl.2013.07.052 |
| Homo sapiens | Beta-2 adrenergic receptor | Ki | 196.0 | nM | None |
| Homo sapiens | Beta-2 adrenergic receptor | Ki | 360.0 | nM | 10.1016/j.bmc.2016.04.028 |
| Homo sapiens | Beta-2 adrenergic receptor | %Max (Mean) | 142.84 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-3 adrenergic receptor | EC50 | 31.0 | nM | 10.1016/j.bmc.2007.11.060 |
| Homo sapiens | Beta-3 adrenergic receptor | EC50 | 49.0 | nM | 10.1016/j.bmc.2007.11.060 |
| Homo sapiens | Beta-3 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-3 adrenergic receptor | Intrinsic activity | 99.0 | % | 10.1016/j.bmc.2007.11.060 |
| Homo sapiens | Beta-3 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Bile salt export pump | AC50 | 300000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Bradykinin B2 receptor | IC50 | nan | None | None |
| Homo sapiens | Bradykinin B2 receptor | Ki | nan | None | None |
| Homo sapiens | Bromodomain-containing protein 4 | Delta TM | -0.08 | C | None |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Inhib (Mean) | -12.3 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Max (Mean) | -2.56 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Caco-2 | logPapp | -6.02 | None | 10.1016/j.bmc.2009.08.022 |
| Homo sapiens | Caco-2 | logPapp | -6.02 | None | 10.1016/j.bmc.2011.03.011 |
| Homo sapiens | Calcitonin receptor | IC50 | nan | None | None |
| Homo sapiens | Calcitonin receptor | Ki | nan | None | None |
| Homo sapiens | Cannabinoid CB1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cannabinoid CB1 receptor | IC50 | nan | None | None |
| Homo sapiens | Cannabinoid CB1 receptor | Ki | nan | None | None |
| Homo sapiens | Carbonic anhydrase I | Ka | 0.09 | uM | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase I | KA | 0.09 | uM | 10.1016/j.bmc.2018.07.011 |
| Homo sapiens | Carbonic anhydrase I | KA | 0.09 | uM | 10.1016/j.bmcl.2016.11.027 |
| Homo sapiens | Carbonic anhydrase I | KA | 0.09 | uM | 10.1016/j.ejmech.2021.113875 |
| Homo sapiens | Carbonic anhydrase I | Kcat | 10.4 | 10^5/s | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase II | IC50 | nan | None | None |
| Homo sapiens | Carbonic anhydrase II | Ka | 96.0 | uM | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase II | KA | 96.0 | uM | 10.1016/j.bmc.2018.07.011 |
| Homo sapiens | Carbonic anhydrase II | KA | 96.0 | uM | 10.1016/j.bmcl.2016.11.027 |
| Homo sapiens | Carbonic anhydrase II | KA | 96.0 | uM | 10.1016/j.ejmech.2021.113875 |
| Homo sapiens | Carbonic anhydrase II | Kcat | 1.7 | 10^6/s | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase II | Ki | nan | None | None |
| Homo sapiens | Carbonic anhydrase IV | Ka | 45.0 | uM | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase IV | KA | 45.0 | uM | 10.1016/j.ejmech.2021.113875 |
| Homo sapiens | Carbonic anhydrase IV | Kcat | 2.9 | 10^6/s | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase VA | Ka | 63.0 | uM | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase VA | KA | 63.0 | uM | 10.1016/j.ejmech.2021.113875 |
| Homo sapiens | Carbonic anhydrase VA | Kcat | 3.9 | 10^5/s | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase VII | Ka | 60.0 | uM | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase VII | KA | 60.0 | uM | 10.1016/j.ejmech.2021.113875 |
| Homo sapiens | Carbonic anhydrase VII | Kcat | 10.4 | 10^5/s | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase XIV | Ka | 36.0 | uM | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Carbonic anhydrase XIV | KA | 36.0 | uM | 10.1016/j.ejmech.2021.113875 |
| Homo sapiens | Carbonic anhydrase XIV | Kcat | 4.5 | 10^5/s | 10.1016/j.bmcl.2006.11.027 |
| Homo sapiens | Casein kinase I delta | Delta TM | 0.02 | C | None |
| Homo sapiens | Caspase-1 | IC50 | nan | None | None |
| Homo sapiens | Caspase-1 | Ki | nan | None | None |
| Homo sapiens | Cathepsin G | IC50 | nan | None | None |
| Homo sapiens | Cathepsin G | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 2 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 2 | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 4 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 4 | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 5 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 5 | Ki | nan | None | None |
| Homo sapiens | Cerebroside-sulfatase | Potency | 13.5 | nM | None |
| Homo sapiens | Cholecystokinin A receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cholecystokinin A receptor | IC50 | nan | None | None |
| Homo sapiens | Cholecystokinin A receptor | Ki | nan | None | None |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Inhib (Mean) | -12.12 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Max (Mean) | -2.85 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Cyclin-dependent kinase 2 | Delta TM | 0.78 | C | None |
| Homo sapiens | Cyclooxygenase-1 | IC50 | nan | None | None |
| Homo sapiens | Cyclooxygenase-1 | Ki | nan | None | None |
| Homo sapiens | Cyclooxygenase-2 | AC50 | 4700.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cyclooxygenase-2 | IC50 | nan | None | None |
| Homo sapiens | Cyclooxygenase-2 | Ki | nan | None | None |
| Homo sapiens | Cysteinyl leukotriene receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Cysteinyl leukotriene receptor 1 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 1A2 | AC50 | 15848.93 | nM | None |
| Homo sapiens | Cytochrome P450 1A2 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 1A2 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2A6 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2A6 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | AC50 | 39810.72 | nM | None |
| Homo sapiens | Cytochrome P450 2D6 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | Potency | 39810.7 | nM | None |
| Homo sapiens | Cytochrome P450 2E1 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2E1 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | Potency | 31622.8 | nM | None |
| Homo sapiens | Delta opioid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Delta opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Delta opioid receptor | Ki | nan | None | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 3548.1 | nM | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 7943.3 | nM | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 8912.5 | nM | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 35481.3 | nM | None |
| Homo sapiens | DNA polymerase kappa | Potency | 1995.3 | nM | None |
| Homo sapiens | DNA polymerase kappa | Potency | 2667.9 | nM | None |
| Homo sapiens | DNA polymerase kappa | Potency | 11220.2 | nM | None |
| Homo sapiens | DNA polymerase kappa | Potency | 26679.5 | nM | None |
| Homo sapiens | Dopamine D1 receptor | AC50 | 32.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D1 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D1 receptor | Kd | 55000.0 | nM | 10.1021/jm950447w |
| Homo sapiens | Dopamine D1 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D1 receptor | Log 1/Kd | -4.74 | None | 10.1021/jm950447w |
| Homo sapiens | Dopamine D1 receptor | Potency | 163.6 | nM | None |
| Homo sapiens | Dopamine D1 receptor | Potency | 410.9 | nM | None |
| Homo sapiens | Dopamine D1 receptor | Potency | 2511.9 | nM | None |
| Homo sapiens | Dopamine D1 receptor | Potency | 3162.3 | nM | None |
| Homo sapiens | Dopamine D2 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D2 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D2 receptor | Ki | 910.0 | nM | 10.1016/j.bmc.2016.04.028 |
| Homo sapiens | Dopamine D2 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D3 receptor | AC50 | 8400.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D3 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D3 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D4 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D4 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine transporter | IC50 | nan | None | None |
| Homo sapiens | Dopamine transporter | Ki | nan | None | None |
| Homo sapiens | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Potency | 794.3 | nM | None |
| Homo sapiens | Endothelin receptor ET-A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Endothelin receptor ET-A | IC50 | nan | None | None |
| Homo sapiens | Endothelin receptor ET-A | Ki | nan | None | None |
| Homo sapiens | Epidermal growth factor receptor erbB1 | IC50 | nan | None | None |
| Homo sapiens | Epidermal growth factor receptor erbB1 | Ki | nan | None | None |
| Homo sapiens | Equilibrative nucleoside transporter 1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor alpha | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor alpha | IC50 | nan | None | None |
| Homo sapiens | Estrogen receptor alpha | Ki | nan | None | None |
| Homo sapiens | Estrogen receptor beta | IC50 | nan | None | None |
| Homo sapiens | Estrogen receptor beta | Ki | nan | None | None |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 53.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 54.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 14985.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15057.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15078.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15171.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16285.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16485.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16657.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 17835.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Growth Rate | -0.14 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.11 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 54.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 44.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 48.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 70.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 88.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 92.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 98.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 99.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 119.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 123.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 126.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 132.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 135.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 142.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 143.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 146.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 150.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 153.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 165.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 168.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 169.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 179.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast growth factor receptor 3 | Delta TM | 0.34 | C | None |
| Homo sapiens | Flap endonuclease 1 | Potency | 10621.3 | nM | None |
| Homo sapiens | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Ghrelin receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Inhib (Mean) | -27.31 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Max (Mean) | -2.632 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | Potency | 25.1 | nM | None |
| Homo sapiens | Glucocorticoid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Glucocorticoid receptor | IC50 | nan | None | None |
| Homo sapiens | Glucocorticoid receptor | Ki | nan | None | None |
| Homo sapiens | Glucocorticoid receptor | Potency | 28183.8 | nM | None |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Inhib (Mean) | -6.15 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Max (Mean) | -3.055 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glycogen synthase kinase-3 beta | Delta TM | -0.28 | C | None |
| Homo sapiens | G-protein coupled receptor 120 | %Inhib (Mean) | 2.695 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 120 | %Max (Mean) | -3.979 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 35 | %Inhib (Mean) | -9.77 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 35 | %Max (Mean) | 8.258 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 82.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Membrane Permeable-Phenotype Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Membrane Permeable-Phenotype Cells (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 22878.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 29842.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 35035.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 45150.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 45535.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 60692.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 68271.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 101135.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Growth Rate | 0.03 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.73 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.83 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.84 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 44.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 78.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 57.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 85.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 88.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 44.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 48.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 64.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 78.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 90.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 91.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 92.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 93.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 27.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 218.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 228.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 244.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 249.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 272.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 293.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 312.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 314.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 315.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 371.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 475.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 482.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 486.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 648.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 678.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 1107.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HERG | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | HERG | IC50 | nan | None | None |
| Homo sapiens | HERG | Ki | nan | None | None |
| Homo sapiens | Histamine H1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histamine H1 receptor | IC50 | nan | None | None |
| Homo sapiens | Histamine H1 receptor | Ki | nan | None | None |
| Homo sapiens | Histamine H2 receptor | IC50 | nan | None | None |
| Homo sapiens | Histamine H2 receptor | Ki | nan | None | None |
| Homo sapiens | Histamine H3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 794.3 | nM | None |
| Homo sapiens | HMG-CoA reductase | IC50 | nan | None | None |
| Homo sapiens | HMG-CoA reductase | Ki | nan | None | None |
| Homo sapiens | Homo sapiens | DILI_Concern | nan | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Homo sapiens | DILI_severity_class | 0.0 | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Hypoxia-inducible factor 1 alpha | Potency | 1584.9 | nM | None |
| Homo sapiens | Interleukin-8 receptor A | IC50 | nan | None | None |
| Homo sapiens | Interleukin-8 receptor A | Ki | nan | None | None |
| Homo sapiens | Interleukin-8 receptor B | IC50 | nan | None | None |
| Homo sapiens | Interleukin-8 receptor B | Ki | nan | None | None |
| Homo sapiens | Kappa opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Kappa opioid receptor | Ki | nan | None | None |
| Homo sapiens | Leukocyte common antigen | IC50 | nan | None | None |
| Homo sapiens | Leukocyte common antigen | Ki | nan | None | None |
| Homo sapiens | Leukocyte elastase | IC50 | nan | None | None |
| Homo sapiens | Leukocyte elastase | Ki | nan | None | None |
| Homo sapiens | Lipoxin A4 receptor | %Inhib (Mean) | -10.32 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lipoxin A4 receptor | %Max (Mean) | -2.884 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lysine-specific demethylase 4D-like | Potency | 7079.5 | nM | None |
| Homo sapiens | MAP kinase ERK1 | IC50 | nan | None | None |
| Homo sapiens | MAP kinase ERK1 | Ki | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Delta TM | 0.21 | C | None |
| Homo sapiens | MAP kinase ERK2 | IC50 | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Ki | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Potency | 3981.1 | nM | None |
| Homo sapiens | MAP kinase p38 alpha | IC50 | nan | None | None |
| Homo sapiens | MAP kinase p38 alpha | Ki | nan | None | None |
| Homo sapiens | Matrix metalloproteinase-1 | IC50 | nan | None | None |
| Homo sapiens | Matrix metalloproteinase-1 | Ki | nan | None | None |
| Homo sapiens | Matrix metalloproteinase 9 | IC50 | nan | None | None |
| Homo sapiens | Matrix metalloproteinase 9 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 3 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Melanocortin receptor 3 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 3 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 4 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 4 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 5 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 5 | Ki | nan | None | None |
| Homo sapiens | Menin/Histone-lysine N-methyltransferase MLL | Potency | 39810.7 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 7943.3 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 11220.2 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 12589.3 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 14125.4 | nM | None |
| Homo sapiens | Monoamine oxidase A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Monoamine oxidase A | IC50 | nan | None | None |
| Homo sapiens | Monoamine oxidase A | Ki | nan | None | None |
| Homo sapiens | Motilin receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | M-phase phosphoprotein 8 | Potency | 37685.8 | nM | None |
| Homo sapiens | Mu opioid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Mu opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Mu opioid receptor | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | Ki | nan | None | None |
| Homo sapiens | Neurokinin 1 receptor | IC50 | nan | None | None |
| Homo sapiens | Neurokinin 1 receptor | Ki | nan | None | None |
| Homo sapiens | Neurokinin 2 receptor | IC50 | nan | None | None |
| Homo sapiens | Neurokinin 2 receptor | Ki | nan | None | None |
| Homo sapiens | Neuronal acetylcholine receptor protein alpha-4 subunit | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Neuropeptide Y receptor type 1 | IC50 | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 1 | Ki | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 2 | IC50 | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 2 | Ki | nan | None | None |
| Homo sapiens | Norepinephrine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Norepinephrine transporter | IC50 | nan | None | None |
| Homo sapiens | Norepinephrine transporter | Ki | nan | None | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 48557.7 | nM | None |
| Homo sapiens | Peregrin | Delta TM | -2.65 | C | None |
| Homo sapiens | Peroxisome proliferator-activated receptor gamma | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 3A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 4D | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 5A | IC50 | nan | None | None |
| Homo sapiens | Phosphodiesterase 5A | Ki | nan | None | None |
| Homo sapiens | Platelet activating factor receptor | IC50 | nan | None | None |
| Homo sapiens | Platelet activating factor receptor | Ki | nan | None | None |
| Homo sapiens | Pregnane X receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Progesterone receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Protein kinase C alpha | IC50 | nan | None | None |
| Homo sapiens | Protein kinase C alpha | Ki | nan | None | None |
| Homo sapiens | Receptor protein-tyrosine kinase erbB-2 | IC50 | nan | None | None |
| Homo sapiens | Receptor protein-tyrosine kinase erbB-2 | Ki | nan | None | None |
| Homo sapiens | Runt-related transcription factor 1/Core-binding factor subunit beta | Potency | 7943.3 | nM | None |
| Homo sapiens | Runt-related transcription factor 1/Core-binding factor subunit beta | Potency | 19952.6 | nM | None |
| Homo sapiens | Serine/threonine-protein kinase Aurora-A | Delta TM | -0.18 | C | None |
| Homo sapiens | Serine/threonine-protein kinase mTOR | Potency | 23280.9 | nM | None |
| Homo sapiens | Serine/threonine-protein kinase mTOR | Potency | 26121.6 | nM | None |
| Homo sapiens | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform | IC50 | nan | None | None |
| Homo sapiens | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform | Ki | nan | None | None |
| Homo sapiens | Serotonin 1a (5-HT1a) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 3a (5-HT3a) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin transporter | IC50 | nan | None | None |
| Homo sapiens | Serotonin transporter | Ki | nan | None | None |
| Homo sapiens | Sigma opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Sigma opioid receptor | Ki | nan | None | None |
| Homo sapiens | Solute carrier family 22 member 1 | Inhibition | 29.1 | % | 10.1021/jm8003152 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Inhib (Mean) | -20.01 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Max (Mean) | -6.82 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Thromboxane-A synthase | IC50 | nan | None | None |
| Homo sapiens | Thromboxane-A synthase | Ki | nan | None | None |
| Homo sapiens | Thyroid stimulating hormone receptor | Potency | 31622.8 | nM | None |
| Homo sapiens | Transcription intermediary factor 1-alpha | Delta TM | -0.05 | C | None |
| Homo sapiens | Type-1 angiotensin II receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Type-1 angiotensin II receptor | %Inhib (Mean) | -19.48 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | %Max (Mean) | -6.4 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Tyrosine-protein kinase ABL | Delta TM | 0.52 | C | None |
| Homo sapiens | Tyrosine-protein kinase FYN | IC50 | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase FYN | Ki | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase LCK | IC50 | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase LCK | Ki | nan | None | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 3162.3 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 3548.1 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 8414.4 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 11885.6 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 18356.4 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 23109.3 | nM | None |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 8571.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 11828.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 14221.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 20657.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 20807.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 26450.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 31171.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 44507.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Growth Rate | 0.36 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.43 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.63 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.71 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.85 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.86 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.9 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.94 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.96 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 84.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 86.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 87.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 88.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 92.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 100.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 48.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 44.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 49.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 54.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 64.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 82.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 88.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 89.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 90.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 93.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 98.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 99.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 100.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 65.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 84.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 87.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 92.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 96.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 105.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 150.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 175.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 195.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 199.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 209.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 215.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 229.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 278.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 333.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Ubiquitin carboxyl-terminal hydrolase 1 | Potency | 63095.7 | nM | None |
| Homo sapiens | Vascular endothelial growth factor receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Vascular endothelial growth factor receptor 1 | Ki | nan | None | None |
| Homo sapiens | Vasoactive intestinal polypeptide receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Vasoactive intestinal polypeptide receptor 1 | Ki | nan | None | None |
| Homo sapiens | Vasopressin V1a receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Vasopressin V1a receptor | IC50 | nan | None | None |
| Homo sapiens | Vasopressin V1a receptor | Ki | nan | None | None |
| Homo sapiens | Vitamin D receptor | Potency | 31622.8 | nM | None |
| Homo sapiens | Vitamin D receptor | Potency | 50118.7 | nM | None |
| Homo sapiens | Vitamin D receptor | Potency | 79432.8 | nM | None |
| Meleagris gallopavo | Erythrocyte beta receptor | Delta G | -7.86 | None | 10.1021/jm00152a017 |
| Methanosarcina thermophila | Carbonic anhydrase | KA | 39.0 | uM | 10.1016/j.bmcl.2016.11.027 |
| Mus musculus | Mus musculus | Activity | 0.13 | uL/g/min | 10.1073/pnas.0705611104 |
| Mus musculus | Mus musculus | Activity | 0.29 | uL/g/min | 10.1073/pnas.0705611104 |
| Mus musculus | Mus musculus | Activity | 0.47 | uL/g/min | 10.1073/pnas.0705611104 |
| Mus musculus | Mus musculus | Activity | 49.1 | % | 10.1073/pnas.0705611104 |
| Mus musculus | Mus musculus | Activity | 50.9 | % | 10.1073/pnas.0705611104 |
| Mus musculus | Mus musculus | Activity | 78.0 | % | 10.1073/pnas.0705611104 |
| Mus musculus | Mus musculus | Activity | nan | None | 10.1073/pnas.0705611104 |
| Mus musculus | Nitric oxide synthase, inducible | IC50 | nan | None | None |
| Mus musculus | Nitric oxide synthase, inducible | Ki | nan | None | None |
| Mus musculus | Solute carrier family 22 member 5 | Activity | nan | None | 10.1124/mol.59.2.358 |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | IC50 | nan | None | None |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | Ki | nan | None | None |
| Oryctolagus cuniculus | Arachidonate 15-lipoxygenase | IC50 | 3279.0 | nM | None |
| Oryctolagus cuniculus | Arachidonate 15-lipoxygenase | Ki | nan | None | None |
| Rattus norvegicus | Adrenergic receptor alpha | IC50 | 17.0 | nM | 10.1021/jm00142a026 |
| Rattus norvegicus | Adrenergic receptor alpha | Relative affinity | 100.0 | None | 10.1021/jm00142a026 |
| Rattus norvegicus | Adrenergic receptor alpha-1 | EC50 | 4073.0 | nM | 10.1021/jm00019a001 |
| Rattus norvegicus | Adrenergic receptor alpha-1 | EC50 | 100000.0 | nM | 10.1021/jm00019a001 |
| Rattus norvegicus | Adrenergic receptor alpha-1 | Ki | 200.0 | nM | 10.1021/jm00142a027 |
| Rattus norvegicus | Adrenergic receptor alpha-1 | Ki | 1600.0 | nM | 10.1021/jm990599h |
| Rattus norvegicus | Adrenergic receptor alpha-1 | Ki | 2400.0 | nM | 10.1021/jm00076a024 |
| Rattus norvegicus | Adrenergic receptor alpha-1 | Ki | 2800.0 | nM | 10.1021/jm990599h |
| Rattus norvegicus | Adrenergic receptor alpha-1 | Ki | 14000.0 | nM | 10.1021/jm00043a007 |
| Rattus norvegicus | Adrenergic receptor alpha-2 | Ki | 13.0 | nM | 10.1021/jm990599h |
| Rattus norvegicus | Adrenergic receptor alpha-2 | Ki | 15.0 | nM | 10.1021/jm990599h |
| Rattus norvegicus | Adrenergic receptor alpha-2 | Ki | 38.0 | nM | 10.1021/jm00076a024 |
| Rattus norvegicus | Adrenergic receptor alpha-2 | Ki | 160.0 | nM | 10.1021/np960482l |
| Rattus norvegicus | Adrenergic receptor beta | EC50 | 230.0 | nM | 10.1021/jm00076a024 |
| Rattus norvegicus | Adrenergic receptor beta | EC50 | 230.0 | nM | 10.1021/jm00118a019 |
| Rattus norvegicus | Adrenergic receptor beta | IC50 | 29000.0 | nM | 10.1021/jm00142a026 |
| Rattus norvegicus | Adrenergic receptor beta | Relative affinity | 100.0 | None | 10.1021/jm00142a026 |
| Rattus norvegicus | Aldose reductase | IC50 | nan | None | None |
| Rattus norvegicus | Aldose reductase | Ki | nan | None | None |
| Rattus norvegicus | Alpha-1a adrenergic receptor | IC50 | 628.0 | nM | None |
| Rattus norvegicus | Alpha-1a adrenergic receptor | Ki | 254.0 | nM | None |
| Rattus norvegicus | Alpha-1b adrenergic receptor | IC50 | 1766.0 | nM | None |
| Rattus norvegicus | Alpha-1b adrenergic receptor | Ki | 977.0 | nM | None |
| Rattus norvegicus | Androgen Receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Androgen Receptor | IC50 | nan | None | None |
| Rattus norvegicus | Androgen Receptor | Ki | nan | None | None |
| Rattus norvegicus | Beta-1 adrenergic receptor | Ki | 1100.0 | nM | 10.1021/jm990599h |
| Rattus norvegicus | Beta-1 adrenergic receptor | Ki | 1200.0 | nM | 10.1021/jm00076a024 |
| Rattus norvegicus | Beta-1 adrenergic receptor | Ki | 2100.0 | nM | 10.1021/jm990599h |
| Rattus norvegicus | Beta-2 adrenergic receptor | Activity | nan | None | 10.1016/j.bmc.2017.10.011 |
| Rattus norvegicus | Beta-2 adrenergic receptor | Ki | 720.0 | nM | 10.1021/jm00076a024 |
| Rattus norvegicus | Catechol O-methyltransferase | Km | 398000.0 | nM | 10.1021/jm00223a022 |
| Rattus norvegicus | Catechol O-methyltransferase | Vmax | 19.8 | nmol/mg/min | 10.1021/jm00223a022 |
| Rattus norvegicus | Cyclooxygenase-1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Dopamine D1 receptor | KL | 980.0 | nM | 10.1021/jm950447w |
| Rattus norvegicus | Dopamine D2 receptor | KL | 128000.0 | nM | 10.1021/jm950447w |
| Rattus norvegicus | GABA receptor alpha-1 subunit | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Rattus norvegicus | Glycine receptor | IC50 | nan | None | None |
| Rattus norvegicus | Glycine receptor | Ki | nan | None | None |
| Rattus norvegicus | Insulin receptor | IC50 | nan | None | None |
| Rattus norvegicus | Insulin receptor | Ki | nan | None | None |
| Rattus norvegicus | Nitric-oxide synthase, brain | IC50 | nan | None | None |
| Rattus norvegicus | Nitric-oxide synthase, brain | Ki | nan | None | None |
| Rattus norvegicus | Rattus norvegicus | Activity | 0.12 | 10'-6mg/kg | 10.1021/jm00204a009 |
| Rattus norvegicus | Rattus norvegicus | ALB | 37700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 38200.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 38300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 39300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 42000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 43700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 43800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 44300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 44700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 260.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 282.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 291.17 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 319.83 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 367.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 368.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 383.4 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 404.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 425.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 42.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 47.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 48.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 48.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 49.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 51.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 53.2 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 53.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 57.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 70.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 74.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 75.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 76.17 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 79.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 82.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 84.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 86.83 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 89.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASO | 0.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASOLE | 0.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.4 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.5 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.8 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 2.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BP | 16.0 | mmHg | 10.1021/jm991004l |
| Rattus norvegicus | Rattus norvegicus | BP | 25.0 | mmHg | 10.1021/jm991004l |
| Rattus norvegicus | Rattus norvegicus | BUN | 136.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 140.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 146.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 153.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 155.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 156.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 160.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 173.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 201.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 99.8 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 100.83 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 101.17 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 101.33 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 101.83 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 102.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 102.67 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 103.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 570.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 653.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 673.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 680.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 715.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 750.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 753.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 802.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 147.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 187.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 191.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 204.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 24000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 27000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 28000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 28330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 30000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 31330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 34000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 34200000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 34670000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 1.5 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 1.6 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 1.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 2.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 2.1 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 2.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | dP/dt | 8416.0 | mmHg s-1 | 10.1021/jm991004l |
| Rattus norvegicus | Rattus norvegicus | EOS | 0.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 26.17 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 53.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 64.5 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 77.17 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 88.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 121.6 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 127.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 147.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.17 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.8 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 1.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1368.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1406.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1526.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1620.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1706.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1790.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1798.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1804.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1823.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 32.57 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 34.52 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 35.4 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 35.47 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 36.07 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 36.22 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 36.95 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 37.23 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 39.46 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | Heart rate | 41.0 | beats min-1 | 10.1021/jm991004l |
| Rattus norvegicus | Rattus norvegicus | HGB | 124000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 126800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 128800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 131800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 132000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 134000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 136700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 140700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 143200.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 75.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 94.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 102.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 104.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 111.2 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 118.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 147.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 159.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 162.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 8.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 8.5 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 8.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 9.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 9.17 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 9.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 7423.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 10984.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 10985.83 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 11755.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 12507.83 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 13213.6 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 13463.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 14257.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 14293.83 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 80.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 80.83 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 84.2 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 84.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 85.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 87.17 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 87.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 89.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 92.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 21.14 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 21.18 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 21.42 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 21.62 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 22.5 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 23.63 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 23.7 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 23.73 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 24.73 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 362700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 363000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 364200.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 364300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 367800.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 372300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 378000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 379000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 381000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 58.17 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 58.22 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 59.03 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 59.37 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 61.18 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 62.33 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 62.57 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 63.47 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 65.37 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 0.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 234.5 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 326.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 354.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 369.4 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 380.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 0.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 1.83 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.17 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.4 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 7.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 10.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 10.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 11.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 12.6 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 13.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 14.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 16.5 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 17.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 884.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1222.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1368.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1616.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1658.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1753.5 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 2115.4 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 2414.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 3216.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 101.2 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 109.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 111.2 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 114.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 118.4 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 122.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 127.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 131.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 133.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 679170.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 904670.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 976000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1016000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1271000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1309330.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1311000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1337000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1430670.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.73 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.81 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.84 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 5.92 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.19 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.55 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.61 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.89 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 58300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 58700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 59200.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 60000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 60300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 60500.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 61000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 63000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 67000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | Ratio | 2250.0 | None | 10.1021/jm00204a009 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5230000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5590000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5640000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5710000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5770000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 6100000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 6110000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 6270000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 6780000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBCNUC | 0.0 | /100WBC | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBCNUC | 0.17 | /100WBC | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 144.7 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 144.85 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 145.07 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 145.52 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 145.67 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 147.16 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 147.57 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 147.8 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 150.1 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | TIME | 0.003333 | hr | 10.1021/jm00204a009 |
| Rattus norvegicus | Rattus norvegicus | Tissue Severity Score | nan | None | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 6.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 12.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 13.8 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 14.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 14.2 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 16.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 18.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 19.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 23.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 8730.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 12500.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 12770.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 13000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 15130.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 15370.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 15820.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 16380.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 17800.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | IC50 | nan | None | None |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Ki | nan | None | None |
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | IC50 | nan | None | None |
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | Ki | nan | None | None |
| Rattus norvegicus | Solute carrier family 22 member 1 | Activity | nan | None | 10.1038/sj.bjp.0702065 |
| Rattus norvegicus | Solute carrier family 22 member 1 | Ki | 1600000.0 | nM | 10.1023/a:1013070128668 |
| Rattus norvegicus | Solute carrier family 22 member 2 | Ki | 1191000.0 | nM | 10.1023/a:1013070128668 |
| Rattus norvegicus | Solute carrier family 22 member 2 | Km | 1900000.0 | nM | 10.1074/jbc.273.47.30915 |
| Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Potency | 21192.3 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | -34.41 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.07 | % | 10.6019/CHEMBL4495565 |
| Staphylococcus aureus | Staphylococcus aureus | Activity | 77.0 | % | 10.1016/j.bmcl.2021.128259 |
| Staphylococcus aureus | Staphylococcus aureus | Activity | 79.0 | % | 10.1016/j.bmcl.2021.128259 |
| Trypanosoma brucei | 6-phospho-1-fructokinase | Potency | 33807.8 | nM | None |
| Trypanosoma brucei brucei | Phosphoglycerate kinase, glycosomal | Potency | 37933.0 | nM | None |
| Trypanosoma cruzi (strain CL Brener) | Carbonic anhydrase-like protein, putative | KA | 100.0 | uM | 10.1016/j.bmc.2018.07.011 |
| None | ADMET | delta logD | -0.9 | None | 10.1021/jm0000564 |
| None | ADMET | F | 20.0 | % | 10.1021/jm0000564 |
| None | ADMET | Kpot A,B | 0.01 | None | 10.1016/s0960-894x(99)00395-9 |
| None | ADMET | Kpot A,B | 0.089 | None | 10.1016/s0960-894x(99)00395-9 |
| None | ADMET | Kpot A,B | 0.09 | None | 10.1016/s0960-894x(99)00395-9 |
| None | ADMET | Kpot A,B | 0.65 | None | 10.1016/s0960-894x(99)00395-9 |
| None | ADMET | logPapp | -6.02 | None | 10.1124/dmd.111.041665 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx900326k |
| None | Hepatotoxicity | HepSE_bilirubinemia | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholecystitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholelithiasis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cirrhosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_Combined Scores | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_elevated liver function tests | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic failure | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic necrosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatomegaly | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_jaundice | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver disease | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver fatty | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver function tests abnormal | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | LTKB_BD DILI severity score | nan | None | 10.1016/j.drudis.2011.05.007 |
| None | No relevant target | LogD | -3.49 | None | 10.1021/jm0000564 |
| None | No relevant target | LogD | -2.59 | None | 10.1124/dmd.111.041665 |
| None | No relevant target | LogP | 0.59 | None | 10.1016/s0960-894x(99)00395-9 |
| None | No relevant target | pKa | 8.59 | None | 10.1016/j.bmc.2007.02.026 |
| None | No relevant target | pKa | 9.5 | None | 10.1021/jm00204a009 |
| None | No relevant target | pKa | 9.9 | None | 10.1021/jm0000564 |
| None | Phospholipidosis | Phospholipidosis | nan | None | 10.1080/15376510701857262 |
| None | Unchecked | Ac50 | 17.78 | uM | None |
| None | Unchecked | Ac50 | 22.39 | uM | None |
| None | Unchecked | AC50 | 17782.8 | nM | None |
| None | Unchecked | AC50 | 22387.2 | nM | None |
| None | Unchecked | Activity | 47.0 | % | 10.1038/nchembio801 |
| None | Unchecked | Activity | 84.0 | % | 10.1021/jm00196a008 |
| None | Unchecked | Activity | nan | None | 10.1038/nchembio801 |
| None | Unchecked | [A]T,L | 4.66 | 10'-8 /no of units.cm'3 | 10.1016/j.bmc.2008.12.063 |
| None | Unchecked | [A]T,L | 26926.0 | /mol.dm'3 | 10.1016/j.bmc.2008.12.063 |
| None | Unchecked | IC50 | 232.0 | nM | None |
| None | Unchecked | IC50 | nan | None | None |
| None | Unchecked | Intrinsic activity | 0.75 | None | 10.1021/jm00207a015 |
| None | Unchecked | KA | 0.019 | uM | 10.1016/j.bmcl.2016.11.027 |
| None | Unchecked | KA | 0.72 | uM | 10.1016/j.bmcl.2016.01.078 |
| None | Unchecked | KA | 4.89 | uM | 10.1016/j.bmc.2018.07.011 |
| None | Unchecked | Kcat | 2.92 | 10'6/s | 10.1016/j.bmcl.2016.11.027 |
| None | Unchecked | Ki | 100.0 | nM | 10.1038/nchembio801 |
| None | Unchecked | Ki | 110.0 | nM | 10.1038/nchembio801 |
| None | Unchecked | Ki | 154.0 | nM | None |
| None | Unchecked | Ki | nan | None | None |
| None | Unchecked | -Log KD | -0.46 | None | 10.1021/jm00354a004 |
| None | Unchecked | pKb | 5.07 | None | 10.1021/jm00207a015 |
| None | Unchecked | Potency | 2818.4 | nM | None |
| None | Unchecked | Potency | 7943.3 | nM | None |
| None | Unchecked | Potency | 12589.3 | nM | None |
| None | Unchecked | Potency | 14125.4 | nM | None |
| None | Unchecked | Potency | 19952.6 | nM | None |
| None | Unchecked | Ratio | 400.0 | None | 10.1021/jm00118a019 |
| None | Unchecked | Ratio Ki | 2.5 | None | 10.1016/j.bmc.2016.04.028 |
